Дисскутабельные вопросы диагностики гиперплазии эндометрия

Обложка

Цитировать

Полный текст

Аннотация

Вопросы диагностики гиперплазии эндометрия остаются дисскутабельными до сих пор, несмотря на многообразие противоречивых научных исследований и интенсивный поиск молекулярно-генетических маркеров гиперплазии эндометрия (ГЭ) и рака эндометрия, пока невозможно выбрать информативные прогностические факторы формирования и развития заболевания.

Об авторах

Ольга Александровна Слюсарева

Российский университет дружбы народов

Email: Lelechka.86@mail.ru
Кафедра акушерства и гинекологии с курсом перинатологии Медицинский факультет

Список литературы

  2. Akesson E., Gallos I.D., Ganesan R. et al. Prognostic significance of estrogen and progesterone receptor expression in LNG-IUS (Mirena) treatment of endometrial hyperplasia: an immunohistochemical study // Acta Obstet Gynecol Scand. — 2010. — Vol. 89, № 3. — P. 393—398.
  3. Allison K.H., Tenpenny E., Reed S.D. Immunohistochemical markers in endometrial hyperplasia: is there a panel with promise? A review // Appl Immunohistochem Mol Morphol. — 2008. — Vol. 16, № 4. — P. 329—343.
  4. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 426. The role of transvaginal ultrasonography in the evaluation of postmenopausal bleeding // Obstet Gynecol. — 2009. — Vol. 113, № 2 pt. 1. — P. 462—464.
  5. Armstrong A.J., Hurd W.W., Elguero S. et al. Diagnosis and management of endometrial hyperplasia // J. Minim Invasive Gynecol. — 2012. — Vol. 19, № 5. — P. 562—571.
  6. Bantysh B.B., Paukov V.S., Cogan E.A. Immunomorfological features of epithelial-stromal relationship with endometrial hyperplasia and cancer / / Archives of Pathology. — 2012. — 74 (3). — P. 22—5.
  7. Bishtavi A.H., Manukhin I.B., Tabakman J.J. Modern ideas of endometrial hyperplasia and endometrial intraepithelial neoplasia // Problems reproduction. — 2010. — № 6. — P. 52—58.
  8. Canaani J., Ilan N., Back S. et al. Heparanase expression increases throughout the endometrial hyperplasia-cancer sequence // Int J Gynaecol Obstet. — 2008. — Vol. 101, № 2. — P. 166—171.
  9. Chakravarty D., Srinivasan R., Ghosh S. et al. Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma // Appl Immunohistochem Mol Morphol. — 2008. — Vol. 16, № 6. — P. 535—542.
  10. Chernuha G.E., Dumanovskaya M.R., Burmenskaya O.V. et al. Expression of genes which regulate apoptosis in different types of endome trial hyperplasia and endometrial carcinoma // Obstetrics and Gynecology. — 2013. — № 1. — P. 63—69.
  11. Goldstein S.R. Modern evaluation of the endometrium // Obstet Gynecol. — 2010. — Vol. 116, № 1. — P. 168—176.
  12. Gynecology. Guidance for practical training: a training manual / Ed. V.E. Radzinsky. 3rd ed. — M.: GEOTAR-Media, 2013. — P. 552.
  13. Jacobs I., Gentry-Maharaj A., Burnell M. et al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort // Lancet Oncol. — 2011. — Vol. 12, № 1. — P. 38—48.
  14. Jankowska A.G., Andrusiewicz M., Fischer N. et al. Expression of hCG and GnRHs and their receptors in endometrial carcinoma and hyperplasia // Int J Gynecol Cancer. — 2010. — Vol. 20, № 1. — P. 92—101.
  15. Landrum L.M., Zuna R.E., Walker J.L. Endometrial Hyperplasia, Estrogen Therapy, and the Prevention of Endometrial Cancer // Clinical Gynecologic Oncology. Eight edition / Di Saia P.J., Creasman W.T. — Elsiver, 2012. — P. 123—129.
  16. Lysenko O.V., Rozhdestvenskaya T.A. Doplerometriya in the diagnosis of endometrial hyperplastic processes // Proc. Abstracts III All-Russian seminar “The reproductive potential of Russia: Kazan reading. Women’s health — the health of the nation”. — Moscow: Publishing House of Journal Status Praesens, 2013. — P. 63—64.
  17. McCormick B.A., Wilburn R.D., Thomas M.A. et al. Endometrial thickness predicts endometrial hyperplasia in patients with polycystic ovary syndrome // Fertil Steril. — 2011. — Vol. 95, № 8. — P. 2625—2627.
  18. Monte N.M., Webster K.A., Neuberg D. et al. Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer. — 2010. — Vol. 70, № 15. — P. 6225—6232.
  19. Nieminen T.T., Gylling A., Abdel-Rahman W.M. et al. Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia // Clin Cancer Res. — 2009. — Vol. 15, № 18. — P. 5772—5783.
  20. Obeidat B., Mohtaseb A., Matalka I. The diagnosis of endometrial hyperplasia on curettage: how reliable is it? // Arch Gynecol Obstet. — 2009. — Vol. 279, № 4. — P. 489—492.
  21. Orbo A., Kaino T., Arnes M. et al. Prognostic markers for coexistent carcinoma in high-risk endometrial hyperplasia with negative D-score: significance of morphometry, hormone receptors and apoptosis for outcome prediction // Acta Obstet Gynecol Scand. — 2009. — Vol. 88, № 1. — P. 1234—1242.
  22. Panova E.A., Totchiev G.F., Maiskov I.Y., Uzdenova A.I., Semyatov S.D. Priority risk factors for endometrial hyperplastic processes // Bulletin of Peoples’ Friendship University of Russia. Series “Medicine. Obstetrics and Gynecology”. — 2010. — № 6. — P. 261—265.
  23. Polyzos N.P., Mauri D., Tsioras S. et al. Intraperitoneal dissemination of endometrial cancer cells after hysteroscopy: a systematic review and meta-analysis // Int J Gynecol Cancer. — 2010. — Vol. 20, № 2. — P. 261—267.
  24. Radzinsky V.E., Ordiyants I.M., Orazmurad A.A. Maternity advice bureau. — 3rd ed. — Moscow: GEOTAR-Media, 2009.
  25. Reproductive health: Manual guide / Ed. V.E. Radzinsky. — Moscow: People’s Friendship University of Russia, 2011.
  26. Salman M.C., Usubutun A., Dogan N.U. et al. The accuracy of frozen section analysis at hysterectomy in patients with atypical endometrial hyperplasia // Clin Exp Obstet Gynecol. — 2009. — Vol. 36, № 1. — P. 31—34.
  27. Song J.Y., Kim J.W., Lee J.K. et al. BAG-1 expression in normal endometrium, endometrial hyperplasia and endometrial cancer // Acta Obstet Gynecol Scand. — 2008. — Vol. 87, № 8. — P. 862—867.
  28. Steinbakk A., Gudlaugsson E., Aasprong O.G. et al. Molecular biomarkers in endometrial hyperplasias predict cancer progression // Am J Obstet Gynecol. — 2011. — Vol. 204, № 4. — P. 357e1—357e12.
  29. Suh-Bergmann E., Hung Y.Y., Armstrong M.A. Complex atypical hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage // Obstet Gynecol. — 2009. — Vol. 114, № 3. — P. 523—529.
  30. Svirsky R., Smorgick N., Rozowski U. et al. Can we rely on blind endometrial biopsy for detection of focal intrauterine pathology? // Am J Obstet Gynecol. — 2008. — Vol. 199, № 2. — P. 115.e1—115.e3.
  31. Tabakman Y.Y. Endometrial Cancer: A Guide for doctors. — M.: Practical Medicine, 2009. — P. 12—19.

© Слюсарева О.А., 2013

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution 4.0 International License.

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах